Cardiovascular and Cognitive Health Initiative
Official title: The Cardiovascular-Cognitive Health Initiative
Run by National Heart Centre Singapore · NCT07829380 · Data updated 2026-11-12
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 99 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | National Heart Centre Singapore Academic / other |
| Locations | 4 sites (Singapore and 3 other locations) |
| Status | Recruiting |
| Started | August 4, 2026 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07829380 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21 and older with cardiovascular disease, who can provide informed consent, including those meeting mild cognitive impairment criteria for the sub-study.
✕Probably not a fit
Individuals without cognitive impairment or who did not experience cognitive improvement with the intervention may not see cognitive benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study examines how memory and thinking are affected in people with cardiovascular disease and whether early detection plus structured interventions can improve cognitive outcomes. It uses a structured approach combining cognitive and cardiovascular care to identify prevalence and profiles of cognitive impairment in this population. An RCT sub-study in mild cognitive impairment will compare cognitive test improvements at 24 weeks between the intervention and usual care arms. Secondary outcomes include changes in memory, processing speed, mental health, frailty, quality of life, and links between cognitive status and cardiovascular treatment plans. The research involves adult participants from three Singaporean hospitals under the National Heart Centre Singapore as lead sponsor.
Why it matters
Potential benefit: If successful, participants may experience improved cognitive function and quality of life through integrated cardiovascular and cognitive care.
How similar studies have gone: Prior work in related areas suggests cognitive and cardiovascular interventions can influence cognitive endpoints, though this specific combination with an RCT in this population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Main Study: * Age ≥ 21 years. * Able and willing (or via legally acceptable representative, LAR, where appropriate) to provide informed consent. RCT Sub-Study (Mild cognitive impairment (MCI) arm): * Meets main study criteria. * Mild cognitive impairment defined by: (i) Montreal cognitive assessment (MoCA) \<26 but ≥21; and/or (ii) impairment in at least one domain on standardized neuropsychological testing and/or (iii) MMSE \<28 but ≥24. Exclusion Criteria: * Neurodegenerative disorders or major psychiatric illnesses that substantially impair cognition. * Terminal illness or advanced major organ disease limiting participation with expected survival of less than 1 year. * Severe depression, anxiety, or stress where participation may be inappropriate. * Any condition which, in the investigator's opinion, would compromise safety or study integrity. Note: Pregnant and breast-feeding women may not take part in this study.
Where it's running
-
National Heart Centre Singapore
Singapore, Singapore Recruiting -
Alexandra Hospital
Singapore, Singapore Not yet recruiting -
Khoo Teck Puat Hospital
Singapore, Singapore Not yet recruiting -
Sengkang General Hospital
Singapore, Singapore Not yet recruiting
Study contacts
- Study coordinator: Angela S. Koh, MBBS
- Email: angela.koh.s.m@singhealth.com.sg
- Phone: +6567048961
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Immediate vs progressive standing dual-task training for older adults with mild to moderate cognitive impairment
This study tests whether starting with immediate standing dual-task training is better or worse than progressively increasing the difficulty for older adults with mild to moderate cognitive impairment.
-
Can a phone version of the Mini-Cog identify cognitive impairment before surgery?
This study tests whether a telephone-based Mini-Cog can reliably detect cognitive impairment in adults 65 and older before they have surgery.
-
Early Cognitive Interventions in Digital Format for Cancer Survivors: Home-Based Training for CRCI
Two digital cognitive training programs done at home (one computerized, one virtual reality) are tested to see if they help adults with cancer-related cognitive changes more than usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.